Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Catumaxomab> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Catumaxomab abstract "Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in patients with metastasizing cancer. It binds to antigens CD3 and EpCAM. It is in clinical trials in the United States currently and is used in Europe. It was developed by Fresenius Biotech and Trion Pharma (Germany).".
- Catumaxomab atcPrefix "L01".
- Catumaxomab atcSuffix "XC09".
- Catumaxomab casNumber "509077-98-9".
- Catumaxomab wikiPageExternalLink www.removab.com.
- Catumaxomab wikiPageID "9042585".
- Catumaxomab wikiPageRevisionID "552420653".
- Catumaxomab atcPrefix "L01".
- Catumaxomab atcSuffix "XC09".
- Catumaxomab casNumber "509077".
- Catumaxomab chemspiderid "NA".
- Catumaxomab hasPhotoCollection Catumaxomab.
- Catumaxomab legalStatus "Rx-only".
- Catumaxomab licenceEu "Removab".
- Catumaxomab mabType "3".
- Catumaxomab routesOfAdministration "intraperitoneal infusion".
- Catumaxomab source "axo".
- Catumaxomab target CD3_(immunology).
- Catumaxomab target Epithelial_cell_adhesion_molecule.
- Catumaxomab tradename "Removab".
- Catumaxomab type "mab".
- Catumaxomab verifiedfields "changed".
- Catumaxomab verifiedrevid "460022109".
- Catumaxomab subject Category:Monoclonal_antibodies_for_tumors.
- Catumaxomab type Abstraction100002137.
- Catumaxomab type Antibody115027189.
- Catumaxomab type Chemical114806838.
- Catumaxomab type Compound114818238.
- Catumaxomab type Macromolecule114944888.
- Catumaxomab type Material114580897.
- Catumaxomab type Matter100020827.
- Catumaxomab type Molecule114682133.
- Catumaxomab type MonoclonalAntibodiesForTumors.
- Catumaxomab type MonoclonalAntibody115029781.
- Catumaxomab type OrganicCompound114727670.
- Catumaxomab type Part113809207.
- Catumaxomab type PhysicalEntity100001930.
- Catumaxomab type Protein114728724.
- Catumaxomab type Relation100031921.
- Catumaxomab type Substance100019613.
- Catumaxomab type Thing100002452.
- Catumaxomab type Unit109465459.
- Catumaxomab type Drug.
- Catumaxomab type DrugProduct.
- Catumaxomab type FunctionalSubstance.
- Catumaxomab comment "Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in patients with metastasizing cancer. It binds to antigens CD3 and EpCAM. It is in clinical trials in the United States currently and is used in Europe. It was developed by Fresenius Biotech and Trion Pharma (Germany).".
- Catumaxomab label "Catumaxomab".
- Catumaxomab label "Catumaxomab".
- Catumaxomab label "Catumaxomab".
- Catumaxomab label "Katumaksomab".
- Catumaxomab label "كاتوماكسوماب".
- Catumaxomab sameAs Catumaxomab.
- Catumaxomab sameAs Catumaxomab.
- Catumaxomab sameAs Katumaksomab.
- Catumaxomab sameAs m.027vn28.
- Catumaxomab sameAs Q408155.
- Catumaxomab sameAs Q408155.
- Catumaxomab sameAs Catumaxomab.
- Catumaxomab wasDerivedFrom Catumaxomab?oldid=552420653.
- Catumaxomab isPrimaryTopicOf Catumaxomab.